Income Tax Expense (Benefit) in USD of Protagonist Therapeutics, Inc from 2014 to Q3 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.
Summary
Protagonist Therapeutics, Inc quarterly/annual Income Tax Expense (Benefit) history and growth rate from 2014 to Q3 2025.
  • Protagonist Therapeutics, Inc Income Tax Expense (Benefit) for the quarter ending September 30, 2025 was $0.000.
  • Protagonist Therapeutics, Inc Income Tax Expense (Benefit) for the twelve months ending September 30, 2025 was $2.16M, a 3.05% decline year-over-year.
  • Protagonist Therapeutics, Inc annual Income Tax Expense (Benefit) for 2024 was $4.22M.
  • Protagonist Therapeutics, Inc annual Income Tax Expense (Benefit) for 2023 was $0.000.
  • Protagonist Therapeutics, Inc annual Income Tax Expense (Benefit) for 2022 was $0.000.
Income Tax Expense (Benefit), Trailing 12 Months (USD)
Income Tax Expense (Benefit), Quarterly (USD)
Income Tax Expense (Benefit), YoY Quarterly Growth (%)
Income Tax Expense (Benefit), Annual (USD)
Income Tax Expense (Benefit), YoY Annual Growth (%)

Protagonist Therapeutics, Inc Quarterly Income Tax Expense (Benefit) (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2025 $2.16M $0 +$420K Jul 1, 2025 Sep 30, 2025 10-Q 2025-11-06
Q2 2025 $1.74M $172K +$848K Apr 1, 2025 Jun 30, 2025 10-Q 2025-08-06
Q1 2025 $894K $0 -$3.33M -100% Jan 1, 2025 Mar 31, 2025 10-Q 2025-05-06
Q4 2024 $4.22M $1.99M +$1.99M Oct 1, 2024 Dec 31, 2024 10-K 2025-02-21
Q3 2024 $2.23M -$420K -$420K Jul 1, 2024 Sep 30, 2024 10-Q 2025-11-06
Q2 2024 $2.65M -$676K -$676K Apr 1, 2024 Jun 30, 2024 10-Q 2025-08-06
Q1 2024 $3.33M $3.33M +$3.33M Jan 1, 2024 Mar 31, 2024 10-Q 2025-05-06
Q4 2023 $0 $0 Oct 1, 2023 Dec 31, 2023 10-K 2024-02-27
Q3 2023 $0 Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-07
Q2 2023 $0 Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-06
Q1 2023 $0 Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-07
Q4 2021 $0 $0 $0 Oct 1, 2021 Dec 31, 2021 10-K 2024-02-27
Q3 2021 $0 $0 $0 Jul 1, 2021 Sep 30, 2021 10-Q 2021-11-03
Q2 2021 $0 $0 -$1.13M -100% Apr 1, 2021 Jun 30, 2021 10-Q 2021-08-04
Q1 2021 $1.13M $0 -$176K -100% Jan 1, 2021 Mar 31, 2021 10-Q 2021-05-04
Q4 2020 $1.31M $0 -$857K -100% Oct 1, 2020 Dec 31, 2020 10-K 2023-03-15
Q3 2020 $2.16M $0 +$102K Jul 1, 2020 Sep 30, 2020 10-Q 2020-11-04
Q2 2020 $2.06M $1.13M +$2.76M Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-04
Q1 2020 -$698K $176K -$7K -3.83% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-04
Q4 2019 -$691K $857K +$1.66M Oct 1, 2019 Dec 31, 2019 10-K 2022-02-28
Q3 2019 -$2.35M -$102K -$102K Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-04
Q2 2019 -$2.25M -$1.63M -$1.63M Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-06
Q1 2019 -$616K $183K +$183K Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-07
Q4 2018 -$799K -$799K Oct 1, 2018 Dec 31, 2018 10-K 2021-03-10
Q3 2018 $0 Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-06
Q2 2018 $0 Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-07
Q1 2018 $0 Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-08

Protagonist Therapeutics, Inc Annual Income Tax Expense (Benefit) (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed
2024 $4.22M +$4.22M Jan 1, 2024 Dec 31, 2024 10-K 2025-02-21
2023 $0 $0 Jan 1, 2023 Dec 31, 2023 10-K 2024-02-27
2022 $0 $0 Jan 1, 2022 Dec 31, 2022 10-K 2024-02-27
2021 $0 -$1.31M -100% Jan 1, 2021 Dec 31, 2021 10-K 2024-02-27
2020 $1.31M +$2M Jan 1, 2020 Dec 31, 2020 10-K 2023-03-15
2019 -$691K +$108K +13.5% Jan 1, 2019 Dec 31, 2019 10-K 2022-02-28
2018 -$799K -$799K Jan 1, 2018 Dec 31, 2018 10-K 2021-03-10
2017 $0 $0 Jan 1, 2017 Dec 31, 2017 10-K 2018-03-07
2016 $0 $0 Jan 1, 2016 Dec 31, 2016 10-K 2018-03-07
2015 $0 $0 Jan 1, 2015 Dec 31, 2015 10-K 2018-03-07
2014 $0 Jan 1, 2014 Dec 31, 2014 10-K 2017-03-07
* An asterisk sign (*) next to the value indicates that the value is likely invalid.